Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in alzheimer's disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
- Merino, J.J.
- Muñetón-Gómez, V.
- Alvárez, M.-I.
- Toledano-Díaz, A.
ISSN: 1875-5828, 1567-2050
Datum der Publikation: 2016
Ausgabe: 13
Nummer: 4
Seiten: 403-412
Art: Artikel